A drug administered to a patient for treatment, listed in
SEER*Rx as a chemotherapeutic,
hormonal or immunotherapy agent should be coded under chemotherapy [#1390],
hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s)
listed in SEER*Rx for that agent. Do not code under the data item,
Other Therapy [NAACCR #1420]. Refer to the
2026 SEER manual
for more information.
|
Trilostane
|
Hormones and hormonal mechanisms
|
|
Yes
|
|
Trioxifene Mesylate
|
Hormones and hormonal mechanisms
|
Breast cancer
|
Yes
|
|
Vismodegib
|
Chemotherapy
|
Basal cell carcinoma, skin
|
Yes
|
|
Volasertib
|
Chemotherapy
|
AML trials,
Ovarian trials,
Solid tumors trials
|
Yes
|
|
Triethylenemelamine
|
Chemotherapy
|
|
Yes
|
|
Romvimza
|
Chemotherapy
|
|
Yes
|
|
Triciribine
|
Chemotherapy
|
|
Yes
|
|
Casodex
|
Hormones and hormonal mechanisms
|
Prostate
|
Yes
|
|
Triamcinolone Hexacetonide
|
Hormones and hormonal mechanisms
|
|
Yes
|
|
Vanflyta
|
Chemotherapy
|
Acute myeloid leukemia,
AML
|
Yes
|
|
Mitosper
|
Chemotherapy
|
|
Yes
|
|
TriGem
|
Biologic therapy (BRM, immunotherapy)
|
Lung,
skin cancer
|
Yes
|
|
Mitomalcin
|
Chemotherapy
|
|
Yes
|
|
Mitolactol
|
Chemotherapy
|
|
Yes
|
|
Mitozolomide
|
Chemotherapy
|
|
Yes
|
|
Mitotane
|
Chemotherapy
|
|
Yes
|
|
Estriol
|
Hormones and hormonal mechanisms
|
|
Yes
|
|
DCC 2036
|
Chemotherapy
|
Chronic myeloid leukemia,
CML
|
Yes
|
|
Estropipate
|
Hormones and hormonal mechanisms
|
|
Yes
|
|
Mitocromin
|
Chemotherapy
|
|
Yes
|
|
Mitopodozide
|
Chemotherapy
|
|
Yes
|
|
Carfilzomib
|
Chemotherapy
|
Multiple myeloma
|
Yes
|
|
PD 0332991
|
Chemotherapy
|
ER positive/ HER2-negative breast cancer
|
Yes
|
|
Ethidium chloride
|
Chemotherapy
|
|
Yes
|
|
MGV Vaccine
|
Biologic therapy (BRM, immunotherapy)
|
Colorectal,
gastric,
lung cancer,
lymphoma,
neuroblastoma,
sarcoma
|
Yes
|
An official website of the United States government
Home